Simulated biopsy in prostatic autopsy specimens-assessment of the lesion distribution and accuracy of prsostate biospy

Simulated biopsy and pathological analysis of the prostatic autopsy specimens

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027752

Enrollment

Unknown

Registered

2019-11-25

Start date

2017-09-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Case series:prsostate biospy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients died naturally with non-fatal prostate cancer

Exclusion criteria

Exclusion criteria: (1) in the original specimens, there were glandular defects, capsule damage, and loss of one or both seminal vesicle glands; (2) in the cut specimens, there were no continuity of glandular defects, capsule or loss of seminal vesicle glands after suturing; (3) prostate cancer was definitely diagnosed in the dead.

Design outcomes

Primary

Measure	Time frame
Pathological diagnosis of prostate cancer;	—

Countries

China

Contacts

Public ContactWeigang Yan

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

ywgpumch@sina.com+86 13641327941

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026